BARCELONA, Spain and DÜSSELDORF, Germany, July 24, 2026 -- Minoryx Therapeutics and Neuraxpharm Group, announce that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has...

Afferent Pharmaceuticals named one of "The Hottest Startups of 2015" by Forbes
Afferent Pharmaceuticals named one of "The Hottest Startups of 2015" by Forbes.